307 related articles for article (PubMed ID: 22923421)
1. BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.
Liu D; Wu WH; Mao YM; Yuan P; Zhang R; Ju FL; Jing ZC
Circ Cardiovasc Genet; 2012 Oct; 5(5):511-8. PubMed ID: 22923421
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
[TBL] [Abstract][Full Text] [Related]
5. [Female gender and pulmonary arterial hypertension: a complex relationship].
Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
[TBL] [Abstract][Full Text] [Related]
6. Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.
Girerd B; Montani D; Eyries M; Yaici A; Sztrymf B; Coulet F; Sitbon O; Simonneau G; Soubrier F; Humbert M
Respir Res; 2010 Jun; 11(1):73. PubMed ID: 20534176
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ
J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968
[TBL] [Abstract][Full Text] [Related]
8. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
[TBL] [Abstract][Full Text] [Related]
10. [Study of the BMPR2 gene in patients with pulmonary arterial hypertension].
Portillo K; Santos S; Madrigal I; Blanco I; Paré C; Borderías L; Peinado VI; Roca J; Milà M; Barberà JA
Arch Bronconeumol; 2010 Mar; 46(3):129-34. PubMed ID: 20096498
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
12. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
Evans JD; Girerd B; Montani D; Wang XJ; Galiè N; Austin ED; Elliott G; Asano K; Grünig E; Yan Y; Jing ZC; Manes A; Palazzini M; Wheeler LA; Nakayama I; Satoh T; Eichstaedt C; Hinderhofer K; Wolf M; Rosenzweig EB; Chung WK; Soubrier F; Simonneau G; Sitbon O; Gräf S; Kaptoge S; Di Angelantonio E; Humbert M; Morrell NW
Lancet Respir Med; 2016 Feb; 4(2):129-37. PubMed ID: 26795434
[TBL] [Abstract][Full Text] [Related]
13. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension.
Elliott CG; Glissmeyer EW; Havlena GT; Carlquist J; McKinney JT; Rich S; McGoon MD; Scholand MB; Kim M; Jensen RL; Schmidt JW; Ward K
Circulation; 2006 May; 113(21):2509-15. PubMed ID: 16717148
[TBL] [Abstract][Full Text] [Related]
14. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.
Austin ED; Phillips JA; Cogan JD; Hamid R; Yu C; Stanton KC; Phillips CA; Wheeler LA; Robbins IM; Newman JH; Loyd JE
Respir Res; 2009 Sep; 10(1):87. PubMed ID: 19785764
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.
Kabata H; Satoh T; Kataoka M; Tamura Y; Ono T; Yamamoto M; Huqun ; Hagiwara K; Fukuda K; Betsuyaku T; Asano K
Respirology; 2013 Oct; 18(7):1076-82. PubMed ID: 23675998
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
18. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
19. Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.
Ulrich S; Szamalek-Hoegel J; Hersberger M; Fischler M; Garcia JS; Huber LC; Grünig E; Janssen B; Speich R
Respiration; 2010; 79(4):279-87. PubMed ID: 19844076
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients.
Liu D; Liu QQ; Eyries M; Wu WH; Yuan P; Zhang R; Soubrier F; Jing ZC
Eur Respir J; 2012 Mar; 39(3):597-603. PubMed ID: 21737554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]